Why the study?
The SARS-CoV-2 spike protein is predicted to translocate into the nucleus due to a novel nuclear localization signal absent in other coronaviruses, but its nuclear translocation remained to be confirmed.
SARS-CoV-2 possesses a unique nuclear localization signal in its spike protein that drives nuclear translocation of both S mRNA and protein, distinguishing it from other pathogenic coronaviruses.
Nuclear spike localization prediction is hypothesis-generating; leaves open functional validation and any clinical relevance.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes severe pathophysiology in vulnerable older populations and appears to be highly pathogenic and more transmissible than other coronaviruses. The spike (S) protein appears to be a major pathogenic factor that contributes to the unique pathogenesis of SARS-CoV-2. Although the S protein is a surface transmembrane type 1 glycoprotein, it has been predicted to be translocated into the nucleus due to the novel nuclear localization signal (NLS) "PRRARSV," which is absent from the S protein of other coronaviruses. Indeed, S proteins translocate into the nucleus in SARS-CoV-2-infected cells. S mRNAs also translocate into the nucleus. S mRNA colocalizes with S protein, aiding the nuclear translocation of S mRNA. While nuclear translocation of nucleoprotein (N) has been shown in many coronaviruses, the nuclear translocation of both S mRNA and S protein reveals a novel feature of SARS-CoV-2.
No takes yet. Share an insight, caveat, or question.
Sattar et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: